Yew Bio Pharm Annual Income Statement (OTCMKTS:YEWB)

Add to My Stocks
$0.33 $0 (0%) YEWB stock closing price Feb 24, 2017 (Closing)

Fundamental analysis of YEWB stock involves analyzing its financial statements, apart from checking the Yew Bio Pharm stock price The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. Like any other income statement, the YEWB income statement also itemizes revenue, operating expenses, and profits for a quarter or year and reflects a YoY revenue growth of $21.85M when compared to the same period in the past. The Yew Bio Pharm profit and loss statement for 2015 shows a profit of $5.28M. Profits have grown from $4.28M YoY. Apart from this an investor should also check Yew Bio Pharm assets and Yew Bio Pharm free cash flow. Yew Bio Pharm revenue for 2015 is $29.57M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011
Yew Bio Pharm Net Sales or Revenues
29.57M7.72M7.43M6.72M5.96M
Cost Of Goods Sold (COGS)22.54M2.13M2.4M1.27M1.12M
Yew Bio Pharm Gross Profit
7.03M5.58M5.03M5.44M4.83M
Research & Development Expense-----
Selling General & Admin Expense1.89M1.3M1.13M3.24M0.78M
Income Before Depreciation Depletion Amortization5.13M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization-----
Non Operating Income0.16M----0.01M
Interest Expense-----
Yew Bio Pharm Pretax Income
5.3M4.28M3.89M2.2M4.04M
Provision for Income Taxes0.01M----
Minority Interest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations5.28M4.28M3.89M2.2M4.04M
Extraordinary Items & Discontinued Operations-----
Yew Bio Pharm Net Income (Profit/Loss)
5.28M4.28M3.89M2.2M4.04M
Average Shares used to compute Diluted EPS52.11M----
Average Shares used to compute Basic EPS52.07M----
Income Before Nonrecurring Items5.29M----
Income from Nonrecurring Items-----
Yew Bio Pharm Earnings Per Share Basic Net
0.10----
Yew Bio Pharm Earnings Per Share Diluted Net
0.10----
EPS Diluted Before Nonrecurring Items0.10----
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common-----
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

Before investing one should read a report on Yew Bio Pharm stock analysis. It helps to look at the following income statement items:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YEWB stock has a topline or revenue of $29.57M for 2015 as per this Yew Bio Pharm revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Yew Bio Pharm historical stock prices provides a lot of details about the firm. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
3.3000
PS ratio (
price sales ratio
)
0.3024
Operating margin
7.6
Net profit margin
7.4
Dividend yield
0%